Table 4 Novel mortality prediction models for ALF-patients receiving ECMO support
Coefficient | OR | 95% CI | |
|---|---|---|---|
Model 1 (pre-ECMO) | |||
Age (per five years) | 0.176 | 1.193 | (1.148 to 1.239) |
Immunocompromised state | 0.958 | 2.605 | (1.316 to 5.158) |
Minute ventilation (L/minute) | 0.098 | 1.103 | (1.014 to 1.199) |
Pre-ECMO hemoglobin (g/dL) | -0.182 | 0.834 | (0.728 to 0.954) |
Pre-ECMO lactate (mmol/L) | 0.013 | 1.013 | (1.004 to 1.023) |
Intercept | -2.083 | ||
Model 2 (Day 1) | |||
Age (per five years) | 0.184 | 1.202 | (1.148 to 1.258) |
Immunocompromised state | 1.093 | 2.984 | (1.394 to 6.391) |
Minute ventilation (L/minute) | 0.137 | 1.147 | (1.030 to 1.276) |
Pre-ECMO hemoglobin (g/dL) | -0.208 | 0.812 | (0.696 to 0.947) |
Day 1 FiO2 (per 10%) | 0.264 | 1.302 | (1.232 to 1.376) |
Day 1 fibrinogen (mg/dL) | -0.002 | 0.998 | (0.996 to 0.999) |
Day 1 norepinephrine (μg/minute/10 kg) | 0.159 | 1.172 | (0.980 to 1.401) |
Day 1 C-reactive protein (mg/L) | -0.004 | 0.996 | (0.992 to 0.999) |
Intercept | -1.893 |